Dungog, Argie Lou .
HRN: 24-08-63 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/15/2023
MUPIROCIN 2%, 15G (TUBE)
11/15/2023
11/21/2023
TOPICAL
Apply Thinly
Bid
Soft Tissue Injury
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes